Professional Documents
Culture Documents
Fatigue, Anxiety, Depression and Sleep Quality in Patients Undergoing Haemodialysis
Fatigue, Anxiety, Depression and Sleep Quality in Patients Undergoing Haemodialysis
Abstract
Objective: Patients undergoing haemodialysis may experience troubling symptoms such as fatigue, anxiety,
depression and sleep quality, which may affect their quality of life. The main objective of this study is to determine
the prevalence of fatigue, anxiety, depression and sleep quality among patients receiving haemodialysis during the
coronavirus disease 2019 (COVID-19) pandemic, and to explore the contributing predictors.
Methods: A cross-sectional and descriptive correlational design using Qualtrics software was performed. Data were
collected using the Functional Assessment of Cancer Therapy-Fatigue (FACT-F), the Hospital Anxiety and Depression
Scale (HADS) and the Pittsburgh Sleep Quality Index (PSQI). Logistic regression analyses were used to explore the
predictors that were associated with fatigue, anxiety, depression and sleep quality.
Results: Of the 123 patients undergoing haemodialysis who participated, 53.7% (n = 66) reported fatigue, 43.9%
(n = 54) reported anxiety, 33.3% (n = 41) reported depression and 56.9% (n = 70) reported poor sleep. Fatigue,
anxiety and sleep quality (P < .05) were significantly associated with being female, and whether family members or
relatives were suspected or confirmed with COVID-19. Logistic regression showed that being within the age group
31–40, having a secondary education level, anxiety, depression and sleep quality were the main predictors affecting
the fatigue group.
Conclusion: Fatigue, anxiety, depression and sleep quality are significant problems for patients receiving
haemodialysis during the COVID-19 pandemic. Appropriate interventions to monitor and reduce fatigue,
psychological problems and sleep quality amongst these patients are needed. This can help to strengthen
preparations for responding to possible future outbreaks or pandemics of infectious diseases for patients receiving
haemodialysis.
Keywords: Haemodialysis, Fatigue, Anxiety, Depression, Sleep quality, COVID-19
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
Al Naamani et al. BMC Nephrology (2021) 22:157 Page 2 of 8
the virus outbreak and patients’ immunity is compro- disorders that could interfere with study participation.
mised due to the disease process [2]. These patients nor- Exclusion criteria included patients who were diagnosed
mally receive regular haemodialysis treatment, three with cancer or dementia.
times a week, in overcrowded and congested halls,
mixed with various age groups from different back- Measures
grounds, making it difficult to adhere to all COVID-19 The questionnaires included detailed demographics,
protection guidelines, especially the application of isola- background history and scales, including the Functional
tion and social distancing. Several studies have reported Assessment of Cancer Therapy-Fatigue (FACT-F), the
that haemodialysis patients have a significantly increased Pittsburgh Sleep Quality Index (PSQI), and the Hospital
risk of transmission of infection with COVID-19 and a Anxiety and Depression Scale (HADS).
higher mortality rate compared with the general popula-
tion [3, 4]. In a single center in Italy where 55 haemodi- Demographics
alysis patients were infected with COVID-19, thirteen Information about participants’ age, sex, marital status,
patients (52%) died [5]. education and occupational status were obtained in the
Patients receiving haemodialysis experience debilitat- survey. In addition, participants were asked whether or
ing psychological symptoms from the exhausting chronic not their relatives had either suspected or confirmed
haemodialysis treatment that negatively impacts on their COVID-19?
mental health [6, 7]. The high prevalence and worrying
consequences of COVID-19 might induce psychological Fatigue
distress among haemodialysis patients. Further under- Fatigue was measured using the FACT-F This instru-
standing of the psychological disturbances that haemodi- ment consists of 13-items that assess self-reported fa-
alysis patients might experience during the COVID-19 tigue over the past seven days [9]. Response options are
pandemic is essential to promote good mental health. on a 5-point Likert scale and range from 0 to 4. Total
Therefore, this study is to determine the prevalence of possible scores of the FACT-F range from 0 to 52. A
fatigue, anxiety, depression and sleep quality among pa- higher score indicates less or no fatigue, whereas a lower
tients receiving haemodialysis during the coronavirus score indicates more fatigue. Alexander et al. detected a
disease 2019 (COVID-19) pandemic, and to explore the cut-off point of equal or less than 36 indicating clinically
contributing predictors. significant fatigue [10]. The original FACT-F showed
strong internal consistency (coefficient alpha 0.93–0.95)
Method and good stability (test-retest r = 0.87) [9, 11].
Study design
The study employed a large-scale cross-sectional, de- Depression and anxiety
scriptive, correlational design. The survey was developed The HADS includes 14 items assessing anxiety (7-items)
using an online platform (Qualtrics). Convenience sam- and depression (7-items), which are rated on a 4-point
pling technique was used to collect responses. Partici- Likert-type response (from 0 to 3) [12]. The scores in
pants were invited, through a link, to complete the each subscale are computed by summing the corre-
questionnaire, which was sent by social media. Upon sponding items, with maximum scores of 21 for each
opening the link, participants were prompted to read the subscale. The recommended cut-off values are ≥8 either
study’s introduction and decide whether they wanted to for anxiety or depression [13]. The HADS showed very
participate. Those who agreed to take part provided con- good internal consistency (Cronbach’s α = .83) [14].
sent by clicking an “I consent to participate” box, pre-
sented prior to the start of the survey. This study Sleep quality
adhered to the Strengthening the Reporting of Observa- The PSQI self-rated questionnaire assesses sleep quality
tional Studies in Epidemiology (STROBE) guideline for over the past month [15]. The PSQI has 19-items that
cross-sectional studies [8]. are categorised into seven components: subjective sleep
quality, sleep latency, sleep duration, habitual sleep effi-
Setting and sampling ciency, sleep disturbances, use of sleep medications and
The participants were recruited from across all Ministry daytime dysfunction. The score for each of the seven
of Health institutions in Oman. The study was per- components can range from 0 to 3. The PSQI global
formed from 1st September 2020 to 20th September score is calculated by the sum of the seven components,
2020. The inclusion criteria for participating in the study which ranges from 0 to 21, with a global score ≥ 5 indi-
were as follows: adult patient older than 18 years; diag- cating poor sleep quality in the previous month. The
nosed with ESKD and receiving haemodialysis for at PSQI has acceptable reliability in Arabic (Cronbach’s
least three months; no known psychiatric or neurological α = .77) [16].
Al Naamani et al. BMC Nephrology (2021) 22:157 Page 3 of 8
according to age, marital status, educational level and secondary education level also significantly predicted fa-
occupation (P>0.05). tigue (p < 0.05).
As shown in Table 1, there were significant differences The logistic regression model of anxiety showed that
in reports of fatigue according to gender (p < 0.05), with patients with fatigue were 7.9 times more likely to have
the highest proportion of fatigue among female partici- anxiety (95% CI: 2.18–24.93; p >.001). Patients with a
pants (42.4% vs 21.1%) compared with the non-fatigue family member with suspected or confirmed COVID-19
groups. There were significant differences in the report- were 4.1 times more likely to have anxiety (95% CI:
ing of fatigue (p < 0.05) according to those with relatives 1.47–11.66; p >.05). Poor sleep was significantly a predi-
with suspected or confirmed COVID-19 (59.1% vs. cator of anxiety (OR: .30; 95% CI: 0.09–0.95; p >.05).
33.3%); they were more likely to have fatigue compared In the depression logistic regression model, fatigue
to the non-fatigue groups. Fatigue groups were more was the strongest predictor with participants being 4.9
likely than non-fatigue groups to have anxiety (85.2% vs. time more likely to suffer depression (95% CI: 1.48–
29%, p < .001), depression (80.5% vs. 40.2%, p < .001) and 16.38; p >.05). The secondary education level also signifi-
poor sleep quality (74.3% vs. 26.4%, p < .001). cantly predicted depression (OR: .29; 95% CI: 0.08–1.01;
Comparisons showed that depression groups were sta- p = .05).
tistically significantly higher in female participants The unemployed patients had the strongest predicator
(43.1% vs. 26.8%) (p < 0.05). Depressed respondents were and were 13.3 times more likely to report poor sleep
significantly more likely that non depressed respondents (95% CI: 0.09–0.95; p >.05). Being married appeared to
to have fatigue (50% vs. 14%, p < .001), anxiety (51.9% vs. be the second predicate of poor sleep (OR 5.41; 95% CI:
18.8%, p < .001) and poor sleep quality (44.3% vs. 18.9%, 1.12–26.28; p = .04). The models showed that patients
p < .001). having fatigue and anxiety were significant predictors of
There were significant differences in reports of anxiety poor sleep.
according to gender (female:46.3% vs. 21.7%) and those
with relatives with suspected or confirmed COVID-19 Discussion
(68.5% vs. 30.4%) (p < 0.05) compared with the non- To our knowledge, this is the first study to examine the
anxiety groups. There were significant differences in the prevalence of fatigue, anxiety, depression and sleep qual-
reporting of anxiety according to fatigue (86% vs. 14%, ity among patients undergoing haemodialysis in a middle
p < .001), depression (68.3% vs. 31.7%, p < .001), and poor eastern country during the COVID-19 pandemic. In this
sleep quality (62.9% vs. 18.9%, p < .001); all of whom study, the prevalence of fatigue, anxiety, depression and
were more likely to have anxiety compared to the non- sleep quality resulting from the pandemic among pa-
anxiety groups. tients having haemodialysis is 53.7, 43.9, 33.3 and 56.9%,
The poor sleeper groups had significantly more female respectively. These results are higher than those found
participants (41.4% vs. 20.8%) as did those with relatives in previous research in patients receiving haemodialysis.
with suspected or confirmed COVID-19 (61.4% vs. Including fatigue (47%) [17], anxiety (17.5%) [18], de-
28.3%) (p < 0.05) compared to the good sleeper groups. pression (28%) [19] and sleep quality (48%) [20].
Poor sleep was more prevalent among participants with Compared to results of previous studies in general
fatigue (78.8% vs. 31.6%, p < .001), anxiety (81.5% vs. populations during the COVID-19 pandemic, the preva-
37.7%, p < .001) and depression (75.6% vs. 47.6%, lence of anxiety, depression and sleep quality in this
p < .001), when compared with the good sleeper group. study was higher [21–23], which may be related to the
high risk of dying of COVID-19 among patients with co-
Predictive factors associated with fatigue, anxiety, morbidities and ESKD [24, 25]. This difference may be
depression and sleep quality partially explained by the different isolation measures
Four logistic regressions were conducted to identify pre- that were applied by countries to reduce the spread of
dictors of fatigue, anxiety, depression and sleep quality COVID-19, which can affect patients receiving haemodi-
(Table 2). alysis. In addition, the varied cultural norms, beliefs and
Five independent variables were significantly associ- values between countries may affect the status of fatigue,
ated with fatigue (Table 2). The strongest predictor of anxiety, depression and sleep quality. Another possible
fatigue was patients with depression were 7.9 times more reason for the differences in prevalence the diversity of
likely to suffer fatigue (95% CI:2.32–27.51; p >.001). The the assessment scale and healthcare system between the
second predicate of fatigue was anxiety; patients with studies.
anxiety were 6.3 times more likely to suffer fatigue (95% The present study indicates that female patients having
CI: 1.76–22.88; p >.001). Participants with poor sleep haemodialysis had the highest levels of fatigue, anxiety,
were 3.8 times (95% CI: 1.26–11.85; p >.001) more likely depression and sleep quality. These findings are consist-
to experience fatigue. The 31–40 age group and ent with general female populations during the COVID-
Al Naamani et al. BMC Nephrology (2021) 22:157 Page 5 of 8
19 pandemic [26–28]. Likewise, in this study, female pa- during the COVID-19 outbreak, and the consequences
tients were significantly associated with anxiety. Which for their family if they were to become infected. Further,
may have been be due to worry about their family several studies have suggested that female gender is
Al Naamani et al. BMC Nephrology (2021) 22:157 Page 6 of 8
Table 2 Logistic regression analyses of factors associated with Fatigue, Depression, Anxiety, Sleep Disturbance Odds Ratio (95% CI)
Fatigue Depression Anxiety Poor Sleep
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Gender
Female Ref
Male 0.77 (0.22–2.76) 0.69 0.50 (0.16–1.53) 0.22 0.44 (0.13–1.56) 0.21 0.81 (0.24–2.68) 0.73
Age
More than 50 Ref
18–30 0.25 (0.01–4.5) 0.34 0.60 (0.05–6.78) 0.67 0.79 (0.06–10.62) 0.86 0.43 (0.05–4.00) 0.46
31–40 0.08 (0.01–1.07) 0.05 0.40 (0.05–3.43) 0.40 0.58 (0.06–5.56) 0.63 0.78 (0.12–5.16) 0.79
41–50 0.12 (0.01–1.49) 0.1 0.60 (0.08–4.40) 0.61 1.37 (0.16–12.12) 0.78 0.22 (0.04–1.34) 0.10
Marital Status
Single Ref
Married 0.34 (0.06–1.78) 0.2 1.19 (0.30–4.77) 0.80 0.28 (0.06–1.25) 0.10 5.41 (1.12–26.28) 0.04
Education Level
Degree Ref
Basic 0.38 (0.018–8.12) 0.53 0.72 (0.08–6.40) 0.77 2.01 (0.15–27.13) 0.60 0.11 (0.01–1.45) 0.09
Secondary 0.26 (0.07–0.99) 0.04 0.29 (0.08–1.01) 0.05 1.68 (0.47–5.95) 0.43 0.43 (0.12–1.53) 0.19
Occupational
Employed Ref
Unemployed 0.23 (0.03–1.84) 0.16 0.66 (0.13–3.43) 0.61 0.39 (0.07–2.22) 0.29 13.36 (1.73–102.97) 0.01
Retired 1.24 (0.14–11.28) 0.84 1.83 (0.27–12.24) 0.53 0.35 (0.04–2.99) 0.34 3.95 (0.71–22.10) 0.12
Families or Relatives Suspected or Confirmed
No Ref
Yes 0.67 (0.21–2.11) 0.49 0.43 (0.15–1.26) 0.12 4.15 (1.47–11.66) 0.01 2.52 (0.92–6.91) 0.07
Fatigue – 4.93 (1.48–16.38) 0.01 7.37 (2.18–24.93) 0.00 3.53 (1.12–11.11) 0.03
Depression 7.98 (2.32–27.51) 0.00 – 0.38 (0.12–1.24) 0.11 0.57 (0.18–1.77) 0.33
Anxiety 6.35 (1.76–22.88) 0.00 0.37 (0.12–1.20) 0.1 – 0.27 (0.08–0.89) 0.03
Poor Sleep 3.86 (1.26–11.85) 0.01 0.57 (0.18–1.80) 0.34 0.30 (0.09–0.95) 0.04 –
associated with increased prevalence of fatigue, anxiety, a significant effect on poor sleep quality in patients re-
depression and sleep quality among patients receiving ceiving haemodialysis [35, 36].
haemodialysis [29–31]. The study has a number of limitations. First, this study
The results of this study show that participants was conducted in Oman, which may limit generalization
have significantly increased risk of fatigue, anxiety to other countries. Second the study utilised a cross-
and sleep quality if their family members are diag- sectional design; therefore, it represents the evaluation
nosed with or have suspected COVID-19. This may of fatigue, anxiety, depression and poor sleep quality at
be due to patients receiving haemodialysis being one point in time, without longitudinal observation of
afraid of infection, either from the hospital setting or participants. Finally, the study relied on the participants’
their families. It has been reported that haemodialysis self-reporting questionnaires to assess psychological
patients who develop COVID-19 have high mortality problems; however, this may differ from a clinical diag-
rates [31, 32]. nostic interview. Further, objective measurement of sleep
In this study, being unemployed appears to be the was not performed in the current study; however, the
highest predicator of poor sleep. Previous research has PSQI questionnaire showed good validity and reliability
reported similar findings [33, 34]. One explanation of to measure sleep quality.
this result is that unemployed patients do not have a Altogether, fatigue, anxiety, depression and sleep qual-
regular routine in their daily lives. in the present study, ity are significant problems for patients undergoing
depression was significantly associated with poor sleep. haemodialysis. The results of the current study have a
Likewise, several studies have found that depression has number of potential implications for interventions to
Al Naamani et al. BMC Nephrology (2021) 22:157 Page 7 of 8
improve psychological wellbeing of these patients. For study was conducted in accordance with relevant guidelines and
example, organizations should provide counselling sup- regulations.
15. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh 35. He S, Zhu J, Jiang W, Ma J, Li G, He Y. Sleep disturbance, negative affect
sleep quality index: a new instrument for psychiatric practice and research. and health-related quality of life in patients with maintenance hemodialysis.
Psychiatry Res. 1989;28(2):193–213. https://doi.org/10.1016/0165-1781 Psychol Health Med. 2019;24(3):294–304. https://doi.org/10.1080/13548506.2
(89)90047-4. 018.1515493.
16. Al Maqbali M, Hughes C, Gracey J, Rankin J, Dunwoody L, Hacker E. 36. Pan K-C, Hung S-Y, Chen C-I, Lu C-Y, Shih M-L, Huang C-Y. Social support as
Validation of the Pittsburgh sleep quality index (PSQI) with Arabic cancer a mediator between sleep disturbances, depressive symptoms, and health-
patients. Sleep Biol Rhythms. 2020;0:1–7. related quality of life in patients undergoing hemodialysis. PLoS One. 2019;
17. Picariello F, Norton S, Moss-Morris R, Macdougall IC, Chilcot J. Fatigue in 14(4):e0216045. https://doi.org/10.1371/journal.pone.0216045.
prevalent Haemodialysis patients predicts all-cause mortality and kidney
transplantation. Ann Behav Med Publ Soc Behav Med. 2019;53(6):501–14.
https://doi.org/10.1093/abm/kay061. Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
18. Xi LC, Michael G, Chen Z, Anuar NHM, Yong KHM, Tagore R. Anxiety and
published maps and institutional affiliations.
depression in haemodialysis patients in relation to dialysis adequacy and
nutritional status. Eur Psychiatry. 2016;33:S388.
19. Chilcot J, Guirguis A, Friedli K, Almond M, Day C, Da Silva-Gane M, et al.
Depression symptoms in Haemodialysis patients predict all-cause mortality
but not kidney transplantation: a cause-specific outcome analysis. Ann
Behav Med Publ Soc Behav Med. 2018;52(1):1–8. https://doi.org/10.1007/
s12160-017-9918-9.
20. Rehman IU, Lai PSM, Lim SK, Lee LH, Khan TM. Sleep disturbance among
Malaysian patients with end-stage renal disease with pruritus. BMC Nephrol.
2019;20(1):102. https://doi.org/10.1186/s12882-019-1294-1.
21. Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S,
Mohammadi M, et al. Prevalence of stress, anxiety, depression among the
general population during the COVID-19 pandemic: a systematic review
and meta-analysis. Glob Health. 2020;16(1):57. https://doi.org/10.1186/s12
992-020-00589-w.
22. Wang C, Pan R, Wan X, Tan Y, Xu L, McIntyre RS, et al. A longitudinal study
on the mental health of general population during the COVID-19 epidemic
in China. Brain Behav Immun. 2020;87:40–8. https://doi.org/10.1016/j.bbi.202
0.04.028.
23. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate Psychological
Responses and Associated Factors during the Initial Stage of the 2019
Coronavirus disease (COVID-19) epidemic among the general population in
China. Int J Environ Res Public Health. 2020;17(5). https://doi.org/10.3390/
ijerph17051729.
24. Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M.
COVID-19 and comorbidities: a systematic review and meta-analysis.
Postgrad Med. 2020;0:1–7.
25. Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al.
Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med.
2020;2:1069–76. https://doi.org/10.1007/s42399-020-00363-4.
26. Morgul E, Bener A, Atak M, Akyel S, Aktaş S, Bhugra D, et al. COVID-19
pandemic and psychological fatigue in Turkey. Int J Soc Psychiatry. 2020:
002076402094188. https://doi.org/10.1177/0020764020941889.
27. Rancans E, Renemane L, Kivite-Urtane A, Ziedonis D. Prevalence and
associated factors of mental disorders in the nationwide primary care
population in Latvia: a cross-sectional study. Ann General Psychiatry. 2020;
19(1):25. https://doi.org/10.1186/s12991-020-00276-5.
28. Yu BY-M, Yeung W-F, Lam JC-S, Yuen SC-S, Lam SC, Chung VC-H, et al.
Prevalence of sleep disturbances during COVID-19 outbreak in an urban
Chinese population: a cross-sectional study. Sleep Med. 2020;74:18–24.
https://doi.org/10.1016/j.sleep.2020.07.009.
29. Keskin G, Engin E. The evaluation of depression, suicidal ideation and
coping strategies in haemodialysis patients with renal failure. J Clin Nurs.
2011;20(19-20):2721–32. https://doi.org/10.1111/j.1365-2702.2010.03669.x.
30. Sabet R, Naghizadeh MM, Azari S. Quality of sleep in dialysis patients. Iran J
Nurs Midwifery Res. 2012;17(4):270–4.
31. Tian C, Zhang B, Liang W, Yang Q, Xiong Q, Jin Q, et al. Fatigue in
Peritoneal Dialysis Patients and an Exploration of Contributing Factors: A
Cross-Sectional Study. J Pain Symptom Manage. 2020;59:1074–1081.e2.
32. Valeri AM, Robbins-Juarez SY, Stevens JS, Ahn W, Rao MK, Radhakrishnan J,
et al. Presentation and outcomes of patients with ESKD and COVID-19. J Am
Soc Nephrol. 2020;31(7):1409–15. https://doi.org/10.1681/ASN.2020040470.
33. Kusuma H, Ropyanto CB, Widyaningsih S, Sujianto U. Relating factors of
insomnia among Haemodialysis patients. Nurse Media J Nurs. 2018;8(1):44–
57. https://doi.org/10.14710/nmjn.v8i1.15741.
34. Ng ESY, Wong PY, Kamaruddin ATH, Lim CTS, Chan YM. Poor sleep quality,
depression and social support are determinants of serum phosphate level
among hemodialysis patients in Malaysia. Int J Environ Res Public Health.
2020;17(14). https://doi.org/10.3390/ijerph17145144.